Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives

Curr Top Med Chem. 2015;15(4):298-308. doi: 10.2174/1568026615666150108122918.

Abstract

Nitric oxide (NO) is known to have dichotomous effects on cancer biology, acting as a pro- or antineoplastic agent. Low concentrations of NO are reported to promote tumor growth, whereas high NO influx acts as a potent tumor repressor, leading to cytotoxicity and apoptosis. There is increasing interest in developing NO-releasing materials as potent tumoricidal agents in which high and localized concentrations of NO may be directly released in a sustained manner to the tumor site. Nanomaterials allied to NO donors have emerged as a promising strategy in cancer treatment. In this context, this review summarizes the roles of NO in cancer biology and highlights the therapeutic potential effects of NO-releasing nanomaterials based on polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles and quantum dots in combating tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Nanomedicine / methods
  • Nanostructures / chemistry*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism*
  • Nitric Oxide / chemistry*
  • Nitric Oxide / metabolism*
  • Nitric Oxide / therapeutic use
  • Nitric Oxide Donors / chemistry
  • Nitric Oxide Donors / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitric Oxide Donors
  • Nitric Oxide